Depression, coronary artery disease, and physical activity: How much exercise is enough?

Clinical Therapeutics

Volumn 36, Issue 11, 2014, Pages 1518-1530

  Peterson, Janey C ^a   Charlson, Mary E ^a   Wells, Martin T ^b   Altemus, Margaret ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Coronary artery disease; Depression; Exercise; Heart rate variability; Interleukin 6

Indexed keywords

C REACTIVE PROTEIN; HYDROCORTISONE; INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOLOGIST; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; ENERGY EXPENDITURE; FEMALE; FOLLOW UP; HEART RATE VARIABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PARASYMPATHETIC TONE; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SALIVA LEVEL; TRANSLUMINAL CORONARY ANGIOPLASTY; AGED; BLOOD; CHEMISTRY; CLINICAL TRIAL; COMORBIDITY; EXERCISE; HEART RATE; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; SALIVA;

AGED; C-REACTIVE PROTEIN; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; EXERCISE; FEMALE; HEART RATE; HUMANS; HYDROCORTISONE; INTERLEUKIN-6; MALE; MIDDLE AGED; MOTOR ACTIVITY; SALIVA;

EID: 84911104358     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2014.10.003     Document Type: Article

References (64)

1. Pirraglia PA, Peterson JC, Williams-Russo P, et al. Depressive symptomatology in coronary artery bypass graft surgery patients. Int J Geriatr Psychiatry. 1999;14:668-680.
2. Peterson JC, Charlson ME, Williams-Russo P, et al. New postoperative depressive symptoms and long-term cardiac outcomes after coronary artery bypass surgery. Am J Geriatr Psychiatry. 2002;10:192-198.
3. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91:999-1005.
4. Charlson M, Peterson JC. Medical comorbidity and late life depression: what is known and what are the unmet needs? Biol Psychiatry. 2002;52:226-235.
5. Alexopoulos GS, Meyers BS, Young RC, et al. 'Vascular depression' hypothesis. Arch Gen Psychiatry. 1997;54:915-922.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
7. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300:2379-2388.
8. Agency for Healthcare Research and Quality (AHRQ) Technology Assessment Program. Randomized trials of secondary prevention programs in coronary artery disease: a systematic review, 2005, Rockville, MD.
9. Taylor RS, Unal B, Critchley JA, Capewell S. Mortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements? Eur J Cardiovasc Prev Rehabil. 2006;13:369-374.
10. Charlson ME, Peterson JC, Boutin-Foster C, et al. Changing health behaviors to improve health outcomes after angioplasty: a randomized trial of net present value versus future value risk communication. Health Educ Res. 2008;23:826-839.
11. Blumenthal JA, Babyak MA, Moore KA, et al. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159:2349-2356.
12. Peterson JC. The adaptive neuroplasticity hypothesis of behavioral maintenance. Neural Plast. 2012;2012:516364.
13. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767-1772.
14. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
15. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J. 2004;25:492-499.
16. Howren MB, Lamkin DM, Suls J. Associations of depression with Creactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171-186.
17. Swardfager W, Herrmann N, Cornish S, et al. Exercise intervention and in.ammatory markers in coronary artery disease: a meta-analysis. Am Heart J. 2012;163:666-676. e1-3.
18. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010;141:122-131.
19. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation. 1993;88:927-934.
20. Levy WC, Cerqueira MD, Harp GD, et al. Effect of endurance exercise training on heart rate variability at rest in healthy young and older men. Am J Cardiol. 1998;82:1236-1241.
21. Iellamo F, Legramante JM, Massaro M, et al. Effects of a residential exercise training on baroreflex sensitivity and heart rate variability in patients with coronary artery disease: A randomized, controlled study. Circulation. 2000;102:2588-2592.
22. Rottenberg J. Cardiac vagal control in depression: a critical analysis. Biol Psychol. 2007;74:200-211.
23. Porges SW. The polyvagal perspective. Biol Psychol. 2007;74:116-143.
24. Olofsson PS, Rosas-Ballina M, Levine YA, Tracey KJ. Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev. 2012;248:188-204.
25. McCaffery JM, Marsland AL, Strohacker K, et al. Factor structure underlying components of allostatic load. PLoS One. 2012;7:e47246.
26. Peterson JC, Charlson ME, Hoffman Z, et al. A randomized controlled trial of positive-affect induction to promote physical activity after percutaneous coronary intervention. Arch Intern Med. 2012;172:329-336.
27. Peterson JC, Link AR, Jobe JB, et al. Developing self-management education in coronary artery disease. Heart Lung. 2014;43:133-139.
28. Lorig K, Fries JF. The arthritis helpbook: a tested self-management program for coping with your arthritis. Reading, MA: Addison-Wesley; 1990.
29. Peterson JC, Czajkowski S, Charlson ME, et al. Translating basic behavioral and social science research to clinical application: the EVOLVE mixed methods approach. J Consult Clin Psychol. 2013;81:217-230.
30. Paffenbarger RS Jr., Blair SN, Lee IM, Hyde RT. Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc. 1993;25:60-70.
31. Wolf AM, Hunter DJ, Colditz GA, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994;23:991-999.
32. Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25:333-341.
33. Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J. Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health. 1993;5:179-193.
34. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied psychological measurement. 1977;1:385-401.
35. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805-1812.
36. Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N. Proinflammatory cytokines in heart failure: doubleedged swords. Heart Fail Rev. 2010;15:543-562.
37. Zacho J, Tybjaerg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 2008;359:1897-1908.
38. Porges SW, Bohrer RE. The analysis of periodic processes in psychophysiological research. In: Cacioppo JT, Tassinary IG, eds. Principles of Psychophysiology: Physical, Social, and Inferential Elements. New York: Cambridge University Press; 1990:708-753.
39. Berntson GG, Bigger JT Jr., Eckberg DL, et al. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology. 1997;34:623-648.
40. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48:817-838.
41. Farmer ME, Locke BZ, Moscicki EK, et al. Physical activity and depressive symptoms: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 1988;128:1340-1351.
42. Camacho TC, Roberts RE, Lazarus NB, et al. Physical activity and depression: evidence from the Alameda County Study. Am J Epidemiol. 1991;134:220-231.
43. Alexopoulos GS. Role of executive function in late-life depression. J Clin Psychiatry. 2003;64(Suppl 14):18-23.
44. Menezes AR, Lavie CJ, Forman DE, et al. Cardiac rehabilitation in the elderly. Prog Cardiovasc Dis. 2014;57:152-159.
45. O'Keefe JH, Franklin B, Lavie CJ. Exercising for health and longevity vs peak performance: different regimens for different goals. Mayo Clinic Proc. 2014;89:1171-1175.
46. Milani RV, Lavie CJ. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med. 2007;120:799-806.
47. Williams PT, Thompson PD. Increased cardiovascular disease mortality associated with excessive exercise in heart attack survivors. Mayo Clinic Proc. 2014;89:1187-1194.
48. Blumenthal JA, Sherwood A, Babyak MA, et al. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol. 2012;60:1053-1063.
49. Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drugeluting stents for patients with multivessel coronary artery disease. Circulation. 2007;116(Suppl 11):I200-I206.
50. Palmerini T, Marzocchi A, Marrozzini C, et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol. 2006;98:54-59.
51. van Domburg RT, Lemos PA, Takkenberg JJ, et al. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease. Eur Heart J. 2005;26:675-681.
52. Walther C, Mobius-Winkler S, Linke A, et al. Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil. 2008;15:107-112.
53. Kop WJ, Weissman NJ, Zhu J, et al. Effects of acute mental stress and exercise on inflammatory markers in patients with coronary artery disease and healthy controls. Am J Cardiol. 2008;101:767-773.
54. Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol. 1999;34:1512-1521.
55. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA. 2001; 286:2107-2113.
56. Raison C, Miller A. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry. 2003;160:1554-1565.
57. Vreeburg SA, Kruijtzer BP, van Pelt J, et al. Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology. 2009;34:1109-1120.
58. Kumari M, Badrick E, Chandola T, et al. Cortisol secretion and fatigue: associations in a community based cohort. Psychoneuroendocrinology. 2009; 13:121-125.
59. Fabian L, McGuire L, Page G, et al. The association of the cortisol awakening response with experimental pain ratings. Psychoneuroendocrinology. 2009;34:1247-1251.
60. Schmidt-Reinwald A, Pruessner J, Hellhammer D, et al. The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm. Life Sci. 1999; 64:1653-1660.
61. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289:3106-3116.
62. Blumenthal JA, Babyak MA, Carney RM, et al. Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc. 2004;36:746-755.
63. Kemp A, Quintana D, KL Felmingham SM, Jelinek H. Depression, cormorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk. PLoS One. 2012;7:e30777.
64. Phillips A, Batty G, Gale C, et al. Generalized anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-cause and cariovascular mortality: the Vietnam experience study. Psychosom Med. 2009;71:395-403.